ECU
NBIX icon

Eisler Capital (UK)’s Neurocrine Biosciences NBIX Stock Holding History

Eisler Capital (UK)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,928
Closed -$4.13M – 250
2024
Q1 		$4.13M Buy
29,928
+23,085
+337% +$3.18M 0.03% 54
2023
Q4 		$902K Buy
+6,843
New +$902K 0.01% 198